Dr. Reddy's Recalls Ranitidine Tablets Due to Microbial Contamination
Dr. Reddy's is recalling specific lots of OTC Ranitidine Hydrochloride tablets because raw material tested positive for Pseudomonas sp.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a significant hazard like microbial contamination (Pseudomonas sp.) in a drug product warrants a 'Severe' rating (Score 4), particularly given the potential for serious injury or hospitalization associated with such pathogens.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling specific lots of Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC. The affected products include Equate brand Maximum Strength Acid Reducer (65 count), Equaline brand maximum strength heartburn relief, and Wal-Zan brand 150 Maximum Strength (24 count). These products were distributed nationwide by Wal-Mart Stores, Inc., Supervalu Inc., and Walgreen Co.
The recall was initiated because a lot of raw material used in the manufacture of the ranitidine was found to be positive for Pseudomonas sp. This indicates microbial contamination of the non-sterile product.
Consumers should check their medication bottles for the specific lot numbers and expiration dates listed in the recall notice. If the product matches the recalled lots, consumers should stop using it and contact the retailer or manufacturer for a refund or replacement.
The recalled product
- Product
- Ranitidine Hydrochloride Tablets, USP, 150 mg, OTC, a) Equate brand Maximum Strength Acid Reducer, 65 count bottle Dist. By: Wal-Mart Stores, Inc., Bentonville, AR 72710, NDC 49035-404-61 b)Equaline brand maximum strength heartburn relief, , DISTRIBUTED BY SUPERVALU INC., EDEN
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — OTC Antacid
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- a)Lot: 5055822
- exp. 03/13
- 5056317
- exp. 03/15
- and 5056507
- exp. 04/15 b)Lot: 7956571C
- exp. 04/15 c)Lot: 7956572A
- exp. 04/15
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15